Banyan Biomarkers is developing the first objective blood test that may rule out the need for CT scans in patients with suspected mild traumatic brain injury.
View Top Employees from Banyan Biomarkers Inc (acquired by bioMerieux)Website | http://www.banyanbio.com |
Revenue | $16 million |
Funding | $26.5 million |
Employees | 20 (20 on RocketReach) |
Founded | 2002 |
Address | 16744 West Bernardo Drive, San Diego, California 92127, US |
Phone | (760) 710-0460 |
Technologies |
JavaScript,
HTML,
Google Analytics
+11 more
(view full list)
|
Industry | Biotechnology Research, Medical Testing & Clinical Laboratories, Biotechnology, Healthcare, Science and Engineering, Health Care, Medical |
Web Rank | 8 Million |
Keywords | Banyan Diagnostics, Banyan Biomarkers |
Competitors | AmberGen, Arbor Vita Corporation, Biosignatures Ltd, IncellDx, Tethys Bioscience, Inc. |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 325413 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies |
Looking for a particular Banyan Biomarkers Inc (acquired by bioMerieux) employee's phone or email?
The Banyan Biomarkers Inc (acquired by bioMerieux) annual revenue was $16 million in 2023.
Ronald Hayes is the President, Founder, Banyan Biomarkers, Inc. Director of Banyan Laboratories of Banyan Biomarkers Inc (acquired by bioMerieux).
20 people are employed at Banyan Biomarkers Inc (acquired by bioMerieux).
Banyan Biomarkers Inc (acquired by bioMerieux) is based in San Diego, California.
The NAICS codes for Banyan Biomarkers Inc (acquired by bioMerieux) are [32, 3254, 325413, 32541, 325].
The SIC codes for Banyan Biomarkers Inc (acquired by bioMerieux) are [28, 283].